Results 91 to 100 of about 19,293 (297)

Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review

open access: yesFrontiers in Oncology, 2021
Background Peritoneal metastasis (PM) is a late-stage manifestation of intra-abdominal malignancies. The current standard of care indicates that cure can only be achieved with cytoreductive surgery (CRS) which is often indicated with concurrent adjuvant ...
D. Yap   +5 more
semanticscholar   +1 more source

BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature. [PDF]

open access: yes, 2019
BackgroundHereditary colon cancer is characterized by the inheritance of an abnormal gene mutation which predisposes to malignancy. Recent advances in genomic medicine have identified mutations in "novel" genes as conferring an increased risk of ...
Ali, Mir   +2 more
core  

Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 436-460, September/October 2025.
Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease.
Pawel Kordowitzki   +6 more
wiley   +1 more source

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study. [PDF]

open access: yes, 2017
Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel repeatable treatment for peritoneal carcinomatosis.
Demartines, N.   +6 more
core   +3 more sources

Meta‐analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

open access: yesBJS Open, 2019
Background Up to 15 per cent of colorectal cancers present with peritoneal metastases (CPM). Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS + HIPEC) aims to achieve macroscopic tumour resection combined with HIPEC to destroy ...
S. Hallam   +4 more
doaj   +1 more source

Sensitivity of Platinum‐Based Chemotherapy and Efficacy of Arsenic Trioxide‐Based Non‐Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real‐World Study

open access: yesCancer Medicine, Volume 14, Issue 18, September 2025.
ABSTRACT Background Cross‐resistance is observed between platinum and Poly (ADP‐ribose) polymerase inhibitors (PARPi). We aim to propose the definition of PARPi resistance and demonstrate the best therapeutic strategy for patients with PARPi resistance.
Rui Gou   +13 more
wiley   +1 more source

Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases

open access: yesWorld Journal of Surgical Oncology
Background Colorectal cancer is the third-most common malignancy worldwide. It has the potential to develop peritoneal metastases (CRPM), which can be treated using cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Raymond Hayler   +8 more
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy: Ideal and reality

open access: yesAsian Journal of Surgery
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a new adjuvant therapy for the treatment of abdominal malignant tumors and metastases, which has shown great potential.
Fan-He Dong   +8 more
doaj   +1 more source

Hypertherme intraperitoneale chemotherapie (HIPEC)

open access: yesHuisarts en wetenschap, 2013
Hemmer PHJ, Van Leeuwen BL. Hyperthermic intraperitoneal chemotherapy (HIPEC). Huisarts Wet 2013;56(1):36-9.Surgery forms the basis of cancer therapy, and surgical resection sometimes improves survival in metastatic disease. One such surgical approach is cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Hemmer, Patrick, Van Leeuwen, Barbara
openaire   +2 more sources

Atypical Presentation of Metastasis of Appendiceal Cancer: Neoplastic Growth Infiltrating an Inguinal Hernia

open access: yesClinical Case Reports, Volume 13, Issue 9, September 2025.
ABSTRACT Although rare, appendiceal cancer can metastasize to unusual sites, including the inguinal canal. In patients with a history of abdominal malignancy presenting with an inguinal hernia, metastatic disease should be considered for adequate recognition and early oncologic intervention.
Peter Mounas   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy